These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14709956)

  • 1. Are high initial doses of olanzapine required to reduce agitation associated with schizophrenia?
    Townsend MH; Baier MB
    J Clin Psychopharmacol; 2004 Feb; 24(1):95-7. PubMed ID: 14709956
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B; Taylor CC; Meehan K
    J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and therapeutic aspects of agitation].
    San L
    Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
    [No Abstract]   [Full Text] [Related]  

  • 5. A naturalistic study of consecutive agitated emergency department patients treated with intramuscular olanzapine prior to consent.
    Damsa C; Adam E; Lazignac C; Mihai A; DE Gregorio F; Lejeune J; Maris S; Clivaz E; Allen MH
    Am J Psychiatry; 2008 Apr; 165(4):535-6. PubMed ID: 18381919
    [No Abstract]   [Full Text] [Related]  

  • 6. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
    Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
    Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
    Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y
    Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480
    [No Abstract]   [Full Text] [Related]  

  • 9. Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
    Mautone A; Scarone S;
    Pharmacopsychiatry; 2011 Jul; 44(5):173-8. PubMed ID: 21751127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute agitation in the elderly.
    Bauwens SF
    Clin Pharm; 1988 Dec; 7(12):865-6. PubMed ID: 2905215
    [No Abstract]   [Full Text] [Related]  

  • 12. Intramuscular olanzapine in the management of acute agitation.
    Tulloch KJ; Zed PJ
    Ann Pharmacother; 2004 Dec; 38(12):2128-35. PubMed ID: 15522977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.
    Jørgensen TR; Emborg C; Dahlen K; Bøgelund M; Carlborg A
    BMC Psychiatry; 2016 Jul; 16():244. PubMed ID: 27421880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.
    Pascual JC; Pérez V; Martín JL; Safont G; Puigdemont D; Alvarez E
    Actas Esp Psiquiatr; 2007; 35(1):47-51. PubMed ID: 17323225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of olanzapine, as needed, to treat acute agitation in juveniles.
    Sheikh RM; Ahmed K
    J Child Adolesc Psychopharmacol; 2002; 12(1):71-3. PubMed ID: 12014599
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Rapid tranquilisation in acute psychotic agitation.
    Hughes L; Fuller G
    Emerg Med J; 2011 Jan; 28(1):77-8. PubMed ID: 21172918
    [No Abstract]   [Full Text] [Related]  

  • 18. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
    Centorrino F; Meyers AL; Ahl J; Cincotta SL; Zun L; Gulliver AH; Kinon BJ; Houston JP
    Hum Psychopharmacol; 2007 Oct; 22(7):455-62. PubMed ID: 17708578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].
    Haffen E; Sechter D
    Rev Prat; 1998 May; 48(10):1123-7. PubMed ID: 9781159
    [No Abstract]   [Full Text] [Related]  

  • 20. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.